The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke
Göbel S, Li ZM, Vogelmann J, Holthoff HP, Degen H, Hermann DM, Gawaz M, Ungerer M, Münch G. PLOS ONE 2013, 8(7):e66960.
The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times
Ungerer M, Li ZM, Baumgartner C, Göbel S, Vogelmann J, Holthoff HP, Bültmann A, Gawaz M, Münch G. PLOS ONE 2013; 8(8):e71193.
Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells
Dovizio M, Maier TH, Alberti S, Di Francesco L, Marcantoni E, Münch G, John C, Suess B, Sgambato A, Steinhilber D, Patrignani P. Mol Pharmacol 84:25–40, July 2013. Get the PDF
Novel antiplatelet drugs in clinical development
Ungerer M, Münch G. Thromb Haemost 2013; 110.
Prolonged TSH Receptor A Subunit Immunization of Female Mice Leads to a Long-Term Model of Graves’ Disease, Tachycardia, and Cardiac Hypertrophy
Holthoff HP, Goebel S, Li Z, Faßbender J,Reimann A, Zeibig S, Lohse M, Münch G, Ungerer M. Endocrinology, April 2015, 156(4):1577–1589. Get the PDF
Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies
Jamasbi J, Megens RTA, Bianchini M, Münch G, Ungerer M, Faussner A, Sherman S, Walker A, Goyal P, Jung S, Brandl R, Weber C, Lorenz R, Elia N, Farndale J, Siess W. J Am Coll Cardiol 2015; 65 (22): 2404-2415.
Expanding the Roster: Developing New Inhibitors of Intravascular Thrombosis
Kleiman NS; Kolandaivelu K. J Am Coll Cardiol 2015; 65 (22): 2416 – 2419.
Rabbit models to study atherosclerosis and its complications – Transgenic vascular protein expression in vivo
Baumgartner C, Brandl J, Münch G, , Ungerer M. Progress in Biophysics and Molecular Biology 121 (2016) 131e141.
Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
Ungerer M, Faßbender J, Li Z, Münch G, Holthoff HP. Clinic Rev Allerg Immunol /2016-016-8562-7. Get the PDF
ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions
Degen H, Borst O, Ziegler M, Mojica Munoz AK, Jamasbi J, Walker B, Göbel S, Fassbender J, Adler K, Brandl R, Münch G, Lorenz R, Siess W, Gawaz M, Ungerer M. J Am Heart Ass 2017, 6:e005991; as of July 27, 2017. Get the PDF